Furthermore, our assessment of circadian rhythms in non-malignant epithelial cells, luminal breast cancer cells, and osteosarcoma cells aligns with prior research28,35–37, underscoring the versatility of our approach in elucidating circadian clock properties across various cancer and tissue types. This evidence concerns the gene CLOCK and cancer.